In mouse skin, a Wnt gradient helped cells lacking p53 spread

Skin that looks normal can contain small groups of cells with mutations. Some remain contained and never form tumors. Why do others gain ground among their neighbors? In a study published in Science, Qiwen Gan, Wei Li, Rachel K. Lex, Zhe Ying and Slobodan Beronja found an advantage in the outer layer of mouse skin, called the epidermis: where a cell signal acted mattered, not just how much of it there was.

The team tracked clones—groups descended from a single cell—that lacked p53, a protein that helps restrain the multiplication of damaged cells. In those clones, progenitor cells, which can produce new skin cells, kept renewing themselves and were less likely to mature into specialized cells. Activity in the Wnt signaling pathway, a system of chemical messages that guides cell growth and fate, was lower at the clone's edge and higher at its center. That difference across space is a gradient.

To separate location from quantity, the researchers experimentally changed Wnt's spatial pattern. Clones with a gradient expanded further than clones with uniformly high Wnt activity, even though the latter had more total Wnt activity. Raising the signal everywhere therefore did not reproduce the advantage of a center-to-edge pattern. The comparison supports a role for the signal's geometry in competition between mutant and normal cells.

Several measurements in the same system underpin that conclusion: labeled cells followed in tissue, Wnt activity imaged cell by cell, gene activity, binding of p53 to deoxyribonucleic acid (DNA), the molecule that stores genetic instructions, and a genetic screen of more than a thousand candidate genes. Together, these methods connect the loss of p53 to clone behavior and let the team test the spatial pattern rather than infer its role from an image alone.

A report by Mount Sinai Health System, which does not name an individual reporter, describes a sharp reduction in expansion when the gradient was disrupted. Its public account gives no numerical effect size. Occupying healthy tissue is also different from forming cancer. The study shows how cells lacking p53 gained ground in this mouse-skin model; it does not show that changing Wnt would prevent tumors in people.

The finding shifts the question from ‘How much growth signal is present?’ to ‘Where does it act?’ The evidence supports a causal role for the Wnt gradient in the expansion of clones lacking p53 in mice. It does not establish a treatment or the fate of those clones in humans. A decisive next test is whether the same spatial arrangement governs cell competition in human tissue and whether changing it alters outcomes relevant to disease.